Atlas Trials

Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer

Clinical trial NCT01057069 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT01057069
Sponsor
The Netherlands Cancer Institute
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Breast Cancer
Start date
2010-01-01
Primary completion
2023-06-01
Enrollment
310

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.